このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Autonomic and Peripheral Neurochemical Responses to Maximal Rowing Exercise

2026年9月15日 更新者:Poznan University of Physical Education

Integrated Autonomic, Neuroendocrine and Peripheral Neurochemical Responses to Maximal Rowing Exercise and Early Recovery in Elite Athletes

The goal of this observational study is to characterize autonomic, neuroendocrine, and peripheral neurochemical responses to maximal rowing exercise and early recovery in highly trained male athletes.

The main questions it aims to answer are:

  • How do circulating concentrations of cortisol, testosterone, dopamine, serotonin, gamma-aminobutyric acid (GABA), and the testosterone-to-cortisol ratio change in response to maximal rowing exercise and during the first hour of recovery?
  • How do autonomic cardiovascular parameters, including heart rate variability, blood pressure variability, and baroreflex sensitivity, change 3 hours after maximal exercise compared with baseline values?
  • Do endocrine, peripheral neurochemical, and autonomic responses demonstrate similar or divergent recovery patterns following maximal exercise?

Participants will:

  • Perform a maximal 6,000-m rowing ergometer test.
  • Undergo venous blood sampling before exercise, immediately after exercise, and 1 hour after exercise recovery for assessment of endocrine and peripheral neurochemical markers.
  • Undergo noninvasive cardiovascular and autonomic assessment using the Task Force Monitor System before exercise and 3 hours after exercise recovery.

調査の概要

詳細な説明

This observational study was conducted to investigate physiological responses to maximal rowing exercise and subsequent recovery in highly trained male athletes. The study employed a repeated-measures design, allowing assessment of exercise-induced changes across multiple physiological systems during distinct phases of recovery.

Participants completed a maximal 6,000-m rowing ergometer test under standardized laboratory conditions. Biological and physiological measurements were collected before exercise and during recovery according to a predefined protocol. Venous blood samples were obtained at baseline, immediately after exercise, and after 1 hour of recovery. Noninvasive autonomic and cardiovascular assessments were performed using the Task Force Monitor System before exercise and after 3 hours of recovery. The protocol was designed to capture both immediate biochemical responses and delayed autonomic recovery following maximal exercise.

The study focused on endocrine, peripheral neurochemical, and autonomic cardiovascular regulation. Peripheral neurochemical markers were assessed from blood samples and interpreted as components of the peripheral physiological response to exercise rather than direct indicators of central nervous system activity.

Data collection was performed under controlled laboratory conditions using standardized procedures. All measurements were obtained by trained investigators using calibrated equipment. Data quality was verified through routine review of laboratory and physiological recordings. Implausible values and technical artifacts were identified and evaluated before statistical analysis.

The planned sample size was based on the availability of elite athletes meeting the inclusion criteria and the repeated-measures design of the study. Statistical analyses were conducted using repeated-measures approaches appropriate for longitudinal within-subject data. Data distribution was assessed prior to analysis. Parametric or non-parametric tests were applied as appropriate. Effect sizes were calculated to complement significance testing. Associations between selected physiological variables were explored using correlation analyses. Missing data were handled using complete-case analysis, with no imputation procedures applied.

研究の種類

観察的

入学 (実際)

15

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Poznań
      • Poznan、Poznań、ポーランド、61-871
        • Poznań University of Physical Education

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

サンプリング方法

非確率サンプル

調査対象母集団

Participants were recruited from the Polish National Rowing Team training at the Olympic Preparation Centre (COS OPO) in Wałcz, Poland.

説明

Inclusion Criteria:

  • Highly trained rowers competing at the national or international level
  • Regular participation in structured rowing training
  • Current sports medical clearance for maximal exercise testing
  • Ability to complete a maximal 6,000-m rowing ergometer test
  • Written informed consent to participate in the study

Exclusion Criteria:

  • Acute illness, infection, or injury before testing
  • Diagnosed cardiovascular, metabolic, neurological, endocrine, or inflammatory disorder
  • Use of medications or supplements that could affect cardiovascular, endocrine, metabolic, or neurochemical responses
  • Inability to complete the maximal 6,000-m rowing ergometer test
  • Inability or refusal to provide blood samples
  • Non-compliance with study procedures or pre-test instructions

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
Male elite rowers
Participants completed a single maximal 6,000-m rowing ergometer test. The intervention was distinguished by a standardized all-out rowing protocol combined with peripheral blood sampling before exercise, immediately after exercise, and after 1 hour of recovery, as well as noninvasive autonomic and cardiovascular assessment at baseline and 3 hours after exercise.
Female elite rowers
Participants completed a single maximal 6,000-m rowing ergometer test. The intervention was distinguished by a standardized all-out rowing protocol combined with peripheral blood sampling before exercise, immediately after exercise, and after 1 hour of recovery, as well as noninvasive autonomic and cardiovascular assessment at baseline and 3 hours after exercise.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change from baseline in serum cortisol concentration
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Marker of hypothalamic-pituitary-adrenal axis activation and exercise-induced endocrine response.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Change from baseline in serum testosterone concentration
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Marker of anabolic status and exercise-induced endocrine response.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Change from baseline in testosterone-to-cortisol ratio (T/C)
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Marker of anabolic-catabolic balance during exercise and recovery.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Change from baseline in serum dopamine concentration
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Peripheral neurochemical marker associated with physiological responses to exercise and recovery.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Change from baseline in serum serotonin concentration
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Peripheral neurochemical marker associated with exercise-induced physiological responses and recovery processes.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Change from baseline in serum gamma-aminobutyric acid (GABA) concentration
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Peripheral neurochemical marker involved in physiological regulatory processes during exercise and recovery.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Change from baseline in systolic blood pressure (sBP)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Continuous beat-to-beat systolic blood pressure measured using the Task Force Monitor System.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in diastolic blood pressure (dBP)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Continuous beat-to-beat diastolic blood pressure measured using the Task Force Monitor System.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in mean blood pressure (mBP)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Continuous beat-to-beat mean arterial pressure measured using the Task Force Monitor System.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in heart rate (HR)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Heart rate derived from continuous electrocardiographic recordings.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in total power spectral density of RR intervals (PSD-RRI)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Total spectral power of heart rate variability obtained from power spectral analysis of RR intervals.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in low-frequency power of RR intervals (LF-RRI)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Low-frequency component of heart rate variability (0.04-0.15 Hz), reflecting combined sympathetic and parasympathetic modulation.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in high-frequency power of RR intervals (HF-RRI)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
High-frequency component of heart rate variability (0.17-0.40 Hz), considered an indicator of parasympathetic modulation.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in LF/HF ratio
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Ratio of low-frequency to high-frequency spectral power used as an index of sympathovagal balance.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in baroreflex sensitivity (BRS)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Index of baroreflex function calculated using the spontaneous sequence method.
Baseline (pre-exercise) and 180 minutes post-exercise.
Change from baseline in baroreflex effectiveness index (BEI)
時間枠:Baseline (pre-exercise) and 180 minutes post-exercise.
Index quantifying the effectiveness of baroreflex-mediated cardiovascular regulation.
Baseline (pre-exercise) and 180 minutes post-exercise.

二次結果の測定

結果測定
メジャーの説明
時間枠
Change from baseline in blood lactate concentration
時間枠:Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
Marker of metabolic response to maximal rowing exercise and early recovery.
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディチェア:Anna Skarpańska-Stejnborn, Professor、Poznan University of Physical Education, Gorzów Wielkopolski; Faculty of Sport Sciences in Gorzów Wielkopolski;

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年6月6日

一次修了 (実際)

2024年11月25日

研究の完了 (実際)

2025年3月3日

試験登録日

最初に提出

2026年6月16日

QC基準を満たした最初の提出物

2026年6月16日

最初の投稿 (実際)

2026年6月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月18日

QC基準を満たした最後の更新が送信されました

2026年9月15日

最終確認日

2024年6月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

Individual participant data sharing has not yet been determined. Future sharing of de-identified data will depend on institutional policies, ethical considerations, participant consent, and planned secondary analyses.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する